Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
More Information Supplier PageRaloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageEpothilone A acts by stabilising microtubule formation at the taxol binding site and causes cell cycle arrest at the G2/M transition, leading to cytotoxicity.
More Information Supplier PageLY317615 (Enzastaurin) is a potent and selective inhibitor of PKC?? with antiproliferative activity (IC50= ~6 nM).
More Information Supplier PageLY317615 (Enzastaurin) is a potent and selective inhibitor of PKC?? with antiproliferative activity (IC50= ~6 nM).
More Information Supplier PageLY317615 (Enzastaurin) is a potent and selective inhibitor of PKC?? with antiproliferative activity (IC50= ~6 nM).
More Information Supplier PageLY317615 (Enzastaurin) is a potent and selective inhibitor of PKC?? with antiproliferative activity (IC50= ~6 nM).
More Information Supplier Page
